Key terms
About INSP
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest INSP news
Mar 22
7:40am ET
Analysts Offer Insights on Healthcare Companies: Bruker (BRKR), Inspire Medical Systems (INSP) and Pfizer (PFE)
Mar 22
5:18am ET
Wells Fargo Releases a Hold Rating on Inspire Medical Systems (INSP)
Mar 21
2:20am ET
Leerink Partners Remains a Hold on Inspire Medical Systems (INSP)
Mar 20
5:11pm ET
Analysts Conflicted on These Healthcare Names: Inspire Medical Systems (INSP), ACELYRIN, INC. (SLRN) and Vera Therapeutics (VERA)
Mar 20
2:38pm ET
LivaNova jumps nearly 12% after saying trial likely to meet primary endpoint
Mar 19
9:53am ET
Snowflake, MongoDB downgraded to Sell: Wall Street’s top analyst calls
Mar 19
8:05am ET
Truist Financial Gives a Buy Rating to Inspire Medical Systems (INSP)
Mar 19
5:54am ET
Inspire Medical initiated with an Overweight at Morgan Stanley
Mar 04
9:10am ET
Inspire Medical growth intact despite GLP-1 fears, says UBS
Feb 27
5:21pm ET
Inspire Medical reports Q3 adjusted EPS 17c vs. 41c last year
Feb 13
6:02am ET
‘Fundamentals Appear Positive’: KeyBanc Suggests 2 MedTech Stocks With up to ~40% Upside
Feb 13
5:09am ET
Inspire Medical Systems: Holding Position Amidst Regulatory Challenges and Market Shifts
Feb 11
1:01am ET
Inspire Medical’s New Regulation Risk – A Cause for Worry?
Feb 07
9:06am ET
Inspire Medical price target raised to $280 from $265 at Truist
Feb 07
8:54am ET
Inspire Medical price target raised to $270 from $240 at Lake Street
Feb 07
8:41am ET
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Qiagen (QGEN) and Inspire Medical Systems (INSP)
Feb 07
8:30am ET
Inspire Medical price target raised to $265 from $230 at BofA
Feb 07
8:27am ET
Inspire Medical Systems: A Hold Rating Amidst Short-Term Uncertainty and Competitive Pressures
Feb 07
7:19am ET
Lost Money in MBLY, BNTX, DADA, INSP or ON? Class Action Suits Filed, Seeking Recovery
Feb 07
7:13am ET
Inspire Medical price target raised to $265 from $220 at UBS
Feb 07
7:10am ET
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Inspire Medical Systems (INSP) and Gilead Sciences (GILD)
Feb 07
6:54am ET
Inspire Medical price target raised to $273 from $242 at Baird
Feb 07
6:53am ET
Inspire Medical price target raised to $250 from $225 at Mizuho
Feb 07
5:31am ET
Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), GE Healthcare Technologies Inc (GEHC) and Inspire Medical Systems (INSP)
Feb 07
4:39am ET
Inspire Medical Systems Engages Investors with Upcoming Meetings
Feb 06
4:14pm ET
Inspire Medical shares jump over 3% after Q4 results surpass estimates
Feb 06
4:09pm ET
Inspire Medical backs FY24 revenue view $775M – $785M, consensus $780.26M
Feb 06
4:08pm ET
Inspire Medical reports Q4 EPS 49c, consensus (10c)
Feb 06
9:55am ET
Tesla downgraded, UPS upgraded: Wall Street’s top analyst calls
Feb 06
8:10am ET
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Astria Therapeutics (ATXS) and Inspire Medical Systems (INSP)
Feb 06
4:45am ET
Inspire Medical resumed with an Overweight at KeyBanc
No recent news articles are available for INSP
INSP Financials
Key terms
Ad Feedback
INSP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
INSP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range